Biovie's three largest insider shareholders as of September 29, 2026 are Terren S Peizer (Director, 18.53K shares), Cuong V Do (President Ceo, 16.12K shares), Cuong V Do (President Ceo, 9.99K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Terren S Peizer | Director, TenPercentOwner | 0 | 18,533 | 18,533 | 40.4% | 16 Aug, 2022 |
| 2 | Cuong V Do | President Ceo | 16,117 | 533 | 16,650 | 36.3% | 28 Aug, 2026 |
| 3 | Joseph M Palumbo | Chief Medical Officer | 6,066 | 0 | 6,066 | 13.2% | 28 Aug, 2026 |
| 4 | Joanne Wendy Kim | Chief Financial Officer | 3,474 | 0 | 3,474 | 7.6% | 28 Aug, 2026 |
| 5 | Amy Suzon Chappell | Director | 727 | 0 | 727 | 1.6% | 28 Aug, 2026 |
| 6 | Steve Gorlin | Director | 104 | 0 | 104 | 0.2% | 05 Dec, 2023 |
| 7 | Robert J Hariri | Director | 61 | 0 | 61 | 0.1% | 05 Dec, 2023 |
| 8 | James Paul Lang | Director | 55 | 0 | 55 | 0.1% | 12 Jan, 2023 |
| 9 | Jonathan M Adams | Evp Liver Cirrhosis Programs | 39 | 0 | 39 | 0.1% | 15 Feb, 2022 |
| 10 | Penelope Markham | Evp Liver Cirrhosis Rd | 38 | 0 | 38 | 0.1% | 22 Feb, 2023 |
| 11 | Richard J Berman | Director | 31 | 0 | 31 | 0.1% | 07 Jan, 2025 |
| 12 | Christopher Reading | Evp Neuroscience Rd | 30 | 0 | 30 | 0.1% | 22 Feb, 2023 |
| 13 | Clarence N. Ahlem | Evp Neuroscience Product Dev. | 30 | 0 | 30 | 0.1% | 21 Feb, 2023 |
| 14 | Sigmund Rogich | Director | 3 | 0 | 3 | 0.0% | 07 Jan, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 27 Aug, 2026 | Cuong V Do | President Ceo | Acquired P | 15,210 | $2.08 | $31.64K | 16,117 | Direct |
| 28 Aug, 2026 | Amy Suzon Chappell | Director | Acquired P | 727 | $2.16 | $1.57K | 727 | Direct |
| 28 Aug, 2026 | Joseph M Palumbo | Chief Medical Officer | Acquired P | 4,843 | $2.16 | $10.46K | 6,036 | Direct |
| 28 Aug, 2026 | Joanne Wendy Kim | Chief Financial Officer | Acquired P | 2,500 | $2.18 | $5.45K | 3,441 | Direct |
| 05 Jan, 2026 | Michael Edward Sherman | Director | Acquired A | 80,000 | $0.00 | $0 | 80,000 | Direct |
| 05 Jan, 2026 | Joseph M Palumbo | Chief Medical Officer | Acquired A | 132,000 | $0.00 | $0 | 132,000 | Direct |
| 05 Jan, 2026 | Cuong V Do | President Ceo | Acquired A | 665,300 | $0.00 | $0 | 665,300 | Indirect |
| 05 Jan, 2026 | Joanne Wendy Kim | Chief Financial Officer | Acquired A | 110,100 | $0.00 | $0 | 110,100 | Direct |
| 05 Jan, 2026 | James Paul Lang | Director | Acquired A | 90,000 | $0.00 | $0 | 90,000 | Direct |
| 05 Jan, 2026 | Kameel D. Farag | Director | Acquired A | 57,500 | $0.00 | $0 | 57,500 | Direct |
| 05 Jan, 2026 | Amy Suzon Chappell | Director | Acquired A | 57,500 | $0.00 | $0 | 57,500 | Direct |
| 05 Jan, 2026 | Sigmund Rogich | Director | Acquired A | 70,000 | $0.00 | $0 | 70,000 | Direct |
| 05 Jan, 2026 | James Paul Lang | Director | Acquired A | 330,500 | $0.00 | $0 | 330,500 | Direct |
| 05 Jan, 2026 | Michael Edward Sherman | Director | Acquired A | 341,100 | $0.00 | $0 | 341,100 | Direct |
| 05 Jan, 2026 | Sigmund Rogich | Director | Acquired A | 141,100 | $0.00 | $0 | 141,100 | Direct |
| 07 Aug, 2025 | Cuong V Do | President Ceo | Acquired P | 5,000 | — | — | 9,992 | Indirect |
| 07 Aug, 2025 | Cuong V Do | President Ceo | Acquired P | 5,000 | — | — | 5,050 | Indirect |
| 20 Nov, 2024 | Michael Edward Sherman | Director | Acquired A | 56,900 | $0.00 | $0 | 5 | Direct |
| 20 Nov, 2024 | James Paul Lang | Director | Acquired A | 61,600 | $0.00 | $0 | 5 | Direct |
| 20 Nov, 2024 | Richard J Berman | Director | Acquired A | 34,200 | $0.00 | $0 | 3 | Direct |